Livzon Pharmaceutical repurchases A-shares on september 24

Livzon Pharmaceutical Group repurchased 128,300 A-shares on September 24, 2025, via the Shenzhen Stock Exchange. The repurchases were executed at prices ranging from RMB 38.64 to RMB 39.13 per share, totaling RMB 4,997,693. These shares are intended for cancellation, though they remain outstanding as of the reporting date.

As of September 24, 2025, the company's issued H-shares remained at 299,807,117, with zero held as treasury stock. A-shares, listed on the Shenzhen Stock Exchange, had a closing balance of 604,293,313 shares on the same date. The repurchased A-shares represent 0.01419% of the issued A-shares (excluding treasury shares) prior to the event.

The company's next day disclosure report confirms all necessary approvals and legal requirements for these share repurchases have been met.